Bioinformatics Analysis Platform Articles & Analysis
17 news found
CD Genomics’ Microbial Biomarker Discovery service simplifies this process by providing a comprehensive solution that includes sample collection, sequencing, data analysis, and biomarker identification. The Microbial Biomarker Discovery service uses CD Genomics’ proprietary MicrobioSeq platform, which combines next-generation sequencing with ...
The Bioinformatics-Analysis is a subdivision of CD Genomics, providing reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction services, and other related data analysis services. ...
Profacgen, a biotechnology company that offers bioinformatics platform to help academic and industrial researchers to explore, understand and analyze complex biological data in various biotechnological programs and projects, recently updated its in silico protein-protein interactions prediction service to meet diversified needs of its customers. ...
CD Genomics provides metatranscriptome sequencing data analysis service using bioinformatics analysis platform, which can comprehensively analyze the dynamic changes of microbial flora. ...
Creative Proteomics Pronalyse’s bioinformatics platform will help you solve these problems and challenges,” said the Senior Scientist of Creative Proteomics. ...
The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. ...
The Biomedical Bioinformatics Platform belongs to CD Genomics and has a good reputation for assisting researchers with data analysis challenges, including NGS data processing, analysis, interpretation, and general genomic data analysis, as well as data mining, statistical modeling, data integration, information ...
Bioinformatics-analysis Platform belongs to CD Genomics, which provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis business. ...
Bioinformatics-analysis Platform belongs to CD Genomics, which provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis business. ...
“This is an exciting time for GeneCentric as we deploy our growing pipeline of RNA-based genomic analysis solutions across multiple tumor types and therapeutic options.” In addition to developing its signature and diagnostic pipeline, GeneCentric will continue to pursue key pharmaceutical and biotechnology collaborations where its core technologies can be used to ...
As an interdisciplinary research field, it has become an important part of biological research nowadays in the storage, analysis and interpretation of experimental data. The field of bioinformatics is highly dynamic, with continuous development of new or updated versions of software tools and databases. ...
“As one of the trusted service providers in the field of biotechnology, CD ComputaBio’s analysis services utilize advanced bioinformatics analysis platforms and mature expertise to help customers meet their project needs. ...
BOSTON, Jan. 8, 2021 /PRNewswire-PRWeb/ -- DermBiont, a clinical-stage biotechnology company developing targeted topical therapeutics, - announced today that its Phase 2a clinical trial with its investigational drug product, DBI-001, in atopic dermatitis, has demonstrated decreases in the abundance in S. aureus, improvement in signs and symptoms of atopic dermatitis, and no safety or ...
The phase 2a trial entailed a single application of drug product to patients' feet while phase 2b trial patients self-applied DBI-001 to their feet once daily for 28 days. Analysis from the trial shows that DBI-001 not only reduces the abundance of T. rubrum (the pathogen most commonly associated with tinea pedis), but that the application of DBI-001 also has a beneficial effect ...
Oslo, April 22, 2020 – NEC OncoImmunity AS today announced analysis results from efforts using AI prediction platforms to design blueprints for SARS-CoV-2 vaccines that can drive potent T-cell responses in the majority of the global population. ...
SureCall software enables clinical researchers to transform raw NGS data into insightful analyses without requiring advanced bioinformatics training or laboratory infrastructure. "In NGS clinical cancer research, analysis is the key," said Dr. ...
Agilent Technologies Inc. (NYSE: A) and Expression Analysis Inc. today announced that Expression Analysis has achieved Certified Service Provider status for the Agilent SureSelect Target Enrichment System. ...